Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Unknown 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Head & Neck 2Thoracic 1Sarcoma 1Myeloid 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Cyclophosphamide 122Cytarabine 111fludarabine 90fludarabine phosphate 79Rituximab 75Azacitidine 74venetoclax 54Methotrexate 52Filgrastim 47Whole-Body Irradiation 45Busulfan 45Tacrolimus 35Etoposide 35Mycophenolic Acid 34Lenalidomide 32Antilymphocyte Serum 32Imatinib Mesylate 31Decitabine 31Granulocyte Colony-Stimulating Factor 30Peripheral Blood Stem Cell Transplantation 29Dexamethasone 29Cyclosporine 29Vincristine 26Melphalan 26Clofarabine 25Alemtuzumab 25Mitoxantrone 24Stem Cell Transplantation 22Radiotherapy 22Dasatinib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Reverse Transcriptase Polymerase Chain Reaction × Other hematologic neoplasm × Clear all
NCT00723203 2014-09-09

Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

City of Hope Medical Center

Phase 2 Terminated
16 enrolled 4 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00428077 2011-09-02

Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
4 enrolled 7 charts
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡